logo
  

HMS Gets EUR 1.4 Mln Order From Automation Device Manufacturer

HMS Networks AB, a supplier of communication technology for industrial automation, Monday said it has received a major order from a European automation device manufacturer to deliver Industrial Ethernet communication based on Ethernet POWERLINK technology for AC drives.

The total volume of the contract is approximately 1.4 million euros over a three years period and consist of hardware shipments and software development.

Thilo Doering, Sales Director Central Europe, Germany, said, "POWERLINK and other industrial networks are growing in importance when connecting machines and devices to get better performance and flexibility in today's manufacturing, strongly supported by trends such as Industrie 4.0 and Industrial Internet of Things. With the best in class and leading Anybus® technology from HMS we enable these trends already today for our customers."

In Sweden, HMS Networks shares were trading at 205 Swedish kronor, up 0.49 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates. Dr. Reddy's Laboratories Ltd. is recalling six lots of Sapropterin Dihydrochloride Powder for Oral Solution 100 mg to the consumer level. According to the U.S. Food and Drug Administration, the recall was due to powder discoloration in some packets leading to decreased potency.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT